Fluid Responsiveness Evaluation in Patients With Acute Circulatory Failure and Arrhythmia With Atrial Fibrillation: Indice Delta ITV / Delta RR

NCT03461094 | Completed

• 1 other identifier: FLUIDRESP ARYTHM
• Study Type: interventional
• Target: 7
• Locations: 1 country
• Sites: 1

Brief Summary

Fluid therapy is often used as first line treatment of acute circulatory failure, aiming an increase in cardiac output (by improving preload) and in tissue perfusion. Depending on left ventricular systolic function, fluid challenge could lead to an increase in cardiac ouput and tissue perfusion, or only detrimental consequences (by fluid overload and aggravation of lung and tissues oedema, increase of morbi-mortality). Patients are defined as responders to fluid therapy if one can observe an increase of cardiac output up to 15% after fluid therapy (500ml of crystalloids): gold standard test used in most of the studies on the subject. Literature reports on heterogenous populations a reproductible and constant response rate to this fluid challenge of 50%. It seems reasonable to dispose of indices allowing to predict fluid responsiveness without resulting in fluid intake. Statics markers have been abandonned for several years and dynamics methods have been developped. In front of arrythmia, validated methods are scarce. Passive leg rising method appears to be the only one and it's validity seems to be less well documented than in sinusal patients. The purpose of this study is to determine a new method to assess fluid responsiveness in arrythmic patients. In atrial fibrillation, RR interval varies widely between cardiac cylces. Systolic interval remain constant. Variations will occure at expense of diastolic interval, or ventricular filling interval. One can reliably assume that when RR is longer, preload is rising. If the patient is on the ascendant part of the Franck-Starling curve, a longer RR should cause au greater VTI (Vitess Time Integral, surrogate of cardiac output). The evaluation by transthoracic echocardiography of the indice delta ITV / delta RR should determine the degree of fluid responsiveness in arrhythmic patients. After decision of fluid expansion, patients will have haemodynamic and echocardiographic data measured, delta ITV / delta RR indice assessed, then passive leg rising and fluid expansion with 500 ml of cristalloids administered, with evaluation of VTI (as surrogate of cardiac output) at each time. Fluid responders will be compared to non-responders to evaluate the diagnostic performances of the indice delta ITV / delta RR.

Conditions

Arrhythmia Atrial

Outcome Measures

Primary Outcomes (1)

• Evaluation of the diagnostic performance of the index deltaI ITV / delta RR

  Increase of 15% or more of stroke volume after fluid therapy

  Fluid therapy taking 20 minutes, with responsiveness evaluation within the 5 minutes following fluid therapy

Secondary Outcomes (2)

• Diagnostic performances of passive leg rising for prediction of fluid responsiveness

  Fluid therapy taking 20 minutes, with responsiveness evaluation within the 5 minutes following fluid therapy

• Diagnostic performances of respiratory variations of inferior vena cava for prediction of fluid responsiveness

  Fluid therapy taking 20 minutes, with responsiveness evaluation within the 5 minutes following fluid therapy

Interventions

Preload assessment and volume expansion DEVICE

Fluid therapy perform

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Hospitalized patients in the units of Surgical ICU and Cardiothoracic ICU of the Universatory Hospital of Poitiers
• With atrial Fibrillation
• With spontaneous ventilation
• With acute circulatory failure and medical decision to fluid therapy (Systolic Arterial Blood Pressure \< 90 mmHg and/or vasopressors agents)
• With no left or right ventricular dysfunction

You may not qualify if:

• Patients \< 18 yrs
• Contraindictions to passive leg rising
• Clinical evidence of hemorrhagic shock
• Cardiogenic shock
• Necessity of fluid expansion in emergency
• No echographic windows

Sponsors & Collaborators

• Poitiers University Hospital: lead

Study Sites (1)

CHU de Poitiers

Poitiers, 86021, France

Location

Study Officials

• Thomas Kerforne

  Poitiers University Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 22, 2018
• First Posted: March 9, 2018
• Study Start: May 17, 2017
• Primary Completion: June 12, 2020
• Study Completion: June 12, 2020
• Last Updated: June 16, 2020

Record last verified: 2020-06

Locations

FR (1)